You are here: Industry Insights > Pfizer

News List

Pfizer to boost COVID-19 pill production with French deal ExpressPharma
January 18, 2022
The decision is part of Pfizer's strategy to boost global production of the pill, Paxlovid, which was found to be nearly 90 per cent effective in preventing hospitalisations and deaths in patients at high risk of severe illness...
US FDA approves drugs from AbbVie and Pfizer to treat eczema ExpressPharma
January 17, 2022
AbbVie’s Rinvoq and Pfizer’s Cibinqo have been approved to treat moderate-to-severe eczema, in patients who do not respond to previous treatment, or when use of other treatments is not recommended...
Pfizer’s Prevnar 20 with Pfizer-BioNTech COVID-19 vaccine shows positive results in phase-III study ExpressPharma
January 13, 2022
responses elicited by Prevnar 20 for all 20 serotypes were similar whether given with a dose of the Pfizer-BioNTech COVID-19 vaccine or with placebo.
Pfizer Drives Cultural Change in Sustainable and Accessible Data with MicroStrategy prnasia
January 11, 2022
MicroStrategy, the US-based enterprise analytics platform, supported Pfizer, an American multinational pharmaceutical and biotechnology corporation, to usher in a future of sustainable data culture.
Pfizer partners with Beam Therapeutics to develop rare disease therapies ExpressPharma
January 11, 2022
Pfizer will collaborate with Beam Therapeutics in a deal worth as much as $1.35 billion to develop therapies for rare genetic diseases.
Pfizer and BioNTech sign new global collaboration agreement to develop first mRNA-based shingles vaccine WorldPharmaNews
January 07, 2022
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a new research, development and commercialization collaboration to develop a potential first mRNA-based vaccine for the prevention of shingles...
Pfizer and BioNTech enter deal to develop first mRNA vaccine for shingles Pharmaceutical-Technology
January 07, 2022
Pfizer and BioNTech have entered a new research, development and marketing partnership for a potential first mRNA-based vaccine to prevent shingles (herpes zoster virus (HZV)).
Pfizer to supply US with 10 million more courses of COVID-19 pills ExpressPharma
January 06, 2022
The Biden administration doubled its order for Pfizer Inc’s oral COVID-19 antiviral treatment, the company and the White House said yesterday, providing the government a total of 20 million courses as it fights a record surge in COVID-19 cases.
Pfizer and Biohaven close collaboration agreements pharmaceutical-business-review
January 06, 2022
pfizer has completed the collaboration transaction with Biohaven Pharmaceuticals to obtain rights to market the latter’s rimegepant and zavegepant outside of the US.
Pfizer and BioNTech receive U.S. FDA Emergency Use Authorization of COVID-19 vaccine booster for individuals 12 years of age and older WorldPharmaNews
January 05, 2022
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced that the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) of a booster dose...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page